ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
about
Genetic variation in an individual human exomeInternet-Based Direct-to-Consumer Genetic Testing: A Systematic ReviewGenomic medicine: considerations for health professionals and the publicFamily tree and ancestry inference: is there a need for a 'generational' consent?Effect of Alzheimer disease genetic risk disclosure on dietary supplement useDirect-to-Consumer Genetic and Genomic Testing: Preparing Nurse Practitioners for Genomic Healthcare.All your data (effectively) belong to us: data practices among direct-to-consumer genetic testing firms.Genetic testing in the epilepsies--report of the ILAE Genetics CommissionInferring genetic ancestry: opportunities, challenges, and implications.Direct to consumer genetic testing: Avoiding a culture warCancer genetic risk assessment and referral patterns in primary careRegional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry.Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directionsRisk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.Technical report: Ethical and policy issues in genetic testing and screening of children.Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers.Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.Emerging issues in public health genomics.Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers.Direct-to-consumer personalized genomic testing.Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.Commentary: Children and predictive genomic testing: disease prevention, research protection, and our future.The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen studyHealth care providers and direct-to-consumer access and advertising of genetic testing in the United StatesInformed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations.Getting personal: Head and neck cancer management in the era of genomic medicine.Analytical Validation of a Personalized Medicine APOL1 Genotyping Assay for Nondiabetic Chronic Kidney Disease Risk Assessment.How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics StudyGenetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations.Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees.Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study.Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical StudiesThe impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.Communicating genetic risk information for common disorders in the era of genomic medicine.Public understandings of genetics and health.Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to 'know' your DNA.A new era in clinical genetic testing for hypertrophic cardiomyopathy.Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
P2860
Q21145035-9104268E-F416-41AE-88CA-1310E278EE9AQ26775070-8E03F0CC-E07B-47C0-92CC-16A0FD18821EQ27499767-F2C58DC1-149C-4B26-AF14-2DCA419F02D2Q28606545-14C04158-5DF3-4C10-B840-C0CB1FF627EAQ28752562-127B3CD3-2F82-4423-9FD9-FB7555A6CFBCQ30474378-4C19DE4A-A8C9-4C57-B686-4E087C039651Q31132459-3930F538-234A-483D-AD11-B2F474587B1BQ33794130-85B3B25B-DF4A-466A-9557-CD9C790FE349Q33847247-A644DFE7-D7A1-463B-BC67-41561E3FB745Q34060535-6748ACBA-5CC8-4B19-9A99-7B0647C3CEDBQ34112137-42F81E1D-D8AE-41E5-B719-97D37D12CBCCQ34131978-FAC4D50F-27B6-4304-BD0F-6F001187AEC7Q34135724-A1CC1842-53B5-4141-802C-42C687487434Q34235711-CFDF235E-B8D8-4A26-9943-B1A366B9CE41Q34328987-B32322F9-43F4-45FD-849B-154E0457C682Q34379754-C41CA774-1A6A-4F63-A552-1E3DC6B3CEC8Q34483451-34D4510D-428D-48DB-9A10-DBFB1A866925Q34496940-E08DFFBC-83FD-4107-B809-1E2DA9DF6358Q34636079-D58496C1-31EE-4A80-8F56-E101476D5839Q35230171-B7841E1C-DDB1-4B85-8D8D-042A9F80C622Q35248032-FA06BEEE-D182-436F-9252-F3F97173F2ECQ35286480-6439296D-D0B0-4657-B667-8C671E620E6FQ35423118-0F39FDF2-6941-450B-818F-CB11E79E9263Q35807814-723B623A-E4A6-4B1D-956D-3AE98F433843Q35907523-D2647795-CB45-4DEB-9B67-A73F7FC2CCEEQ35946640-C7EEAADA-358E-4AAB-A9B9-001061CB1A92Q36303715-695A3693-C8CE-4AB0-93A8-AE54AD9C4B94Q36753746-7E8EC70A-92BC-4764-A726-29A60D28388DQ37050375-5AFC7F87-A54E-44F6-9BE6-F6B2C3C4CC3FQ37133904-98EDDCB3-DD8E-485F-954C-2ABE47C1B455Q37136376-14BEB3A4-B80E-4B13-8D3F-7A6B6AF6772BQ37170455-98C010FC-C134-475A-A387-EB620E1F0251Q37171548-C56A5B66-CF6C-4B79-B478-42470B4B0B8BQ37184695-02A9E582-852C-4168-AE67-AF5A0F717803Q37355229-D0292713-195E-42D4-8E0C-174DB2162878Q37389775-782DE4CA-3551-4FAA-A316-F7723B8F9FDFQ37679305-ED1E5101-675F-468A-A32F-220EDD7D1445Q37743582-0338AEB5-230B-4182-B467-139E31A46995Q37766176-9A78E839-7ED4-4EB3-AAD9-3C46E3597060Q37842125-564CB53D-BF2F-4141-8DEF-234CFECDAADF
P2860
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
description
im Dezember 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2007
@uk
name
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@en
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@nl
type
label
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@en
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@nl
prefLabel
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@en
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@nl
P2093
P1476
ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States
@en
P2093
Gail Javitt
Kathy Hudson
Peter Byers
P304
P356
10.1097/01.AOG.0000292086.98514.8B
P407
P50
P577
2007-12-01T00:00:00Z